These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9600629)

  • 21. Anticancer Potential of β-Carboline Alkaloids: An Updated Mechanistic Overview.
    Tshikhudo PP; Mabhaudhi T; Koorbanally NA; Mudau FN; Avendaño Caceres EO; Popa D; Calina D; Sharifi-Rad J
    Chem Biodivers; 2024 Feb; 21(2):e202301263. PubMed ID: 38108650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of harmane and other β-carbolines on apomorphine-induced licking behavior in rat.
    Farzin D; Haghparast A; Motaman S; Baryar F; Mansouri N
    Pharmacol Biochem Behav; 2011 Apr; 98(2):215-9. PubMed ID: 21237191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain.
    Zubaran C; Shoaib M; Stolerman IP; Pablo J; Mash DC
    Neuropsychopharmacology; 1999 Jul; 21(1):119-26. PubMed ID: 10379526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of some beta-carbolines on phenylethylamine and apomorphine stereotypies in rats.
    Kari I; Rapakko S; Airaksinen MM
    Pharmacol Biochem Behav; 1980 Jun; 12(6):979-82. PubMed ID: 7190704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation.
    Im JH; Jin YR; Lee JJ; Yu JY; Han XH; Im SH; Hong JT; Yoo HS; Pyo MY; Yun YP
    Vascul Pharmacol; 2009; 50(5-6):147-52. PubMed ID: 19073282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity.
    House RV; Thomas PT; Bhargava HN
    Pharmacology; 1995 Jun; 51(1):56-65. PubMed ID: 7568345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.
    Deecher DC; Teitler M; Soderlund DM; Bornmann WG; Kuehne ME; Glick SD
    Brain Res; 1992 Feb; 571(2):242-7. PubMed ID: 1377086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative stimulus control by the anxiogenic beta-carboline FG 7142: generalization to a physiological stressor.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1988 Jun; 30(2):351-5. PubMed ID: 3174766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harmala alkaloids and related beta-carbolines: a myoclonic model and antimyoclonic drugs.
    Pranzatelli MR; Snodgrass SR
    Exp Neurol; 1987 Jun; 96(3):703-19. PubMed ID: 3495451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of beta-carboline alkaloids on the object recognition task in mice.
    Moura DJ; Rorig C; Vieira DL; Henriques JA; Roesler R; Saffi J; Boeira JM
    Life Sci; 2006 Oct; 79(22):2099-104. PubMed ID: 16904699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites.
    Airaksinen MM; Mikkonen E
    Med Biol; 1980 Dec; 58(6):341-4. PubMed ID: 6112290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosensor based on inhibition of monoamine oxidases A and B for detection of β-carbolines.
    Radulescu MC; Bucur MP; Bucur B; Radu GL
    Talanta; 2015 May; 137():94-9. PubMed ID: 25770611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines.
    Nielsen EB; White FJ; Holohean AM; Callahan PM; Appel JB
    Life Sci; 1982 Nov; 31(22):2433-9. PubMed ID: 7154844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Peganum harmala or its beta-carboline alkaloids on certain antibiotic resistant strains of bacteria and protozoa from poultry.
    Arshad N; Zitterl-Eglseer K; Hasnain S; Hess M
    Phytother Res; 2008 Nov; 22(11):1533-8. PubMed ID: 18814210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
    Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
    J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidative properties of harmane and beta-carboline alkaloids.
    Tse SY; Mak IT; Dickens BF
    Biochem Pharmacol; 1991 Jul; 42(3):459-64. PubMed ID: 1859459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of carbolines and some GABA receptor ligands with the GABA and the benzodiazepine receptors.
    Mousah H; Jacqmin P; Lesne M
    J Pharmacol; 1986; 17(4):686-91. PubMed ID: 3031382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
    Yang XM; Luo ZP; Zhou JH
    J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of beta-carbolines with central dopaminergic transmission in mice: structure-activity relationships.
    Pimpinella G; Palmery M
    Neurosci Lett; 1995 Apr; 189(2):121-4. PubMed ID: 7609916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-carbolines, psychoactive compounds in the mammalian body. Part I: Occurrence, origin and metabolism.
    Airaksinen MM; Kari I
    Med Biol; 1981 Feb; 59(1):21-34. PubMed ID: 7022042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.